RINGTX
Live / Allowed — Notice of allowance issued (as of 21 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99022541
- Mark type
- Word mark
- Filed
- 29 Jan 2025
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of human diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
- Class 040 — Treatment of materials: Custom manufacture of anelloviruses
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Jul 2025 — NON-FINAL ACTION E-MAILED
- 10 Jul 2025 — NON-FINAL ACTION WRITTEN
- 09 Jul 2025 — ASSIGNED TO EXAMINER
- 30 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Jan 2025 — NEW APPLICATION ENTERED